The gamble between oncolytic virus therapy and IFN

Qingbo Li(Tianjin Medical University Eye Hospital), Shan Cen(Jewish General Hospital)
Frontiers in Immunology
August 25, 2022
10.3389/fimmu.2022.971674
Cited by 45

Related Papers

SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis
|Signal Transduction and Targeted Therapy|2022|24
MxB Disrupts Hepatitis C Virus NS5A–CypA Complex: Insights From a Combined Theoretical and Experimental Approach
|Frontiers in Microbiology|2022|7
Repurposing of Berbamine Hydrochloride to Inhibit Ebola Virus by Targeting Viral Glycoprotein
|Research Square|2020|1